Time of issue:2019-07-09 00:00:00
- Categories:About us
- Time of issue:2019-05-29 00:00:00
Founded in 2014, Wuhan Bio-Raid Biotechnology Co., Ltd. is a high-tech enterprise focusing on CAR-T cell immunotherapy.
Bio-Raid has developed a number of patented technologies, and established a broad pipeline of CAR-T product candidates covering blood and solid tumors and HIV areas of significant unmet medical need.
Bio-Raid will speed up the research process and intend to submit 5 INDs to CDE from 2019 to 2021. We hope to Promote cellular immunotherapy technology to clinical application as soon as possible.